Champions Oncology Inc (CSBR) — Cash Flow-to-Debt Ratio
Champions Oncology Inc (CSBR) has a Cash Flow-to-Debt Ratio of -0.06x as of January 2026, meaning its operating cash flow of $-1.34 Million could theoretically repay 0% of its total liabilities ($24.07 Million) in one year. See Champions Oncology Inc (CSBR) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Champions Oncology Inc Cash Flow-to-Debt Ratio (1996–2025)
Historical debt coverage capacity for Champions Oncology Inc across 30 annual periods. For the full cash flow conversion analysis, see Champions Oncology Inc (CSBR) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Champions Oncology Inc (1996–2025)
Year-by-year debt coverage analysis for Champions Oncology Inc. Check Champions Oncology Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | $7.39 Million | $28.57 Million | ▲ +218.1% |
| 2024 | -0.22x | $-6.14 Million | $28.04 Million | ▼ -264.2% |
| 2023 | 0.13x | $3.96 Million | $29.68 Million | ▼ -46.1% |
| 2022 | 0.25x | $6.50 Million | $26.28 Million | ▲ +396.5% |
| 2021 | -0.08x | $-1.68 Million | $20.16 Million | ▼ -144.9% |
| 2020 | 0.19x | $2.90 Million | $15.65 Million | ▼ -10.0% |
| 2019 | 0.21x | $1.86 Million | $9.03 Million | ▲ +236.3% |
| 2018 | -0.15x | $-1.23 Million | $8.10 Million | ▲ +59.5% |
| 2017 | -0.37x | $-2.84 Million | $7.61 Million | ▲ +68.0% |
| 2016 | -1.16x | $-6.45 Million | $5.54 Million | ▲ +51.8% |
| 2015 | -2.41x | $-9.63 Million | $3.99 Million | ▼ -298.8% |
| 2014 | -0.61x | $-3.43 Million | $5.67 Million | ▲ +41.9% |
| 2013 | -1.04x | $-4.26 Million | $4.09 Million | ▼ -143.3% |
| 2012 | -0.43x | $-5.23 Million | $12.20 Million | ▼ -9921.6% |
| 2011 | 0.00x | $-54.00K | $12.63 Million | ▲ +99.5% |
| 2010 | -0.89x | $-2.10 Million | $2.35 Million | ▼ -171.5% |
| 2009 | -0.33x | $-888.00K | $2.70 Million | ▼ -142.0% |
| 2008 | 0.78x | $792.40K | $1.01 Million | ▲ +543.0% |
| 2007 | -0.18x | $-78.47K | $444.82K | ▼ -26.0% |
| 2006 | -0.14x | $-93.97K | $671.05K | ▼ -149.1% |
| 2005 | -0.06x | $-35.60K | $633.34K | ▲ +62.2% |
| 2004 | -0.15x | $-72.05K | $484.62K | ▲ +58.2% |
| 2003 | -0.36x | $-248.12K | $696.91K | ▼ -761.3% |
| 2002 | -0.04x | $-32.68K | $790.69K | ▼ -120.7% |
| 2001 | 0.20x | $144.68K | $725.18K | ▲ +670.6% |
| 2000 | -0.03x | $-18.35K | $524.78K | ▼ -114.6% |
| 1999 | 0.24x | $110.00K | $460.00K | ▼ -77.8% |
| 1998 | 1.08x | $420.00K | $390.00K | ▲ +242.7% |
| 1997 | 0.31x | $110.00K | $350.00K | ▲ +424.8% |
| 1996 | -0.10x | $-30.00K | $310.00K | — |